Mitigating Adverse Effects Following GPRC5DTargeted Therapy in Multiple Myeloma
A panel of experts in multiple myeloma discussed strategies for monitoring and mitigating adverse effects associated with GPRC5D-targeting bispecific agents.
Evaluating Immunotherapy Options Based on Mutations for NSCLC
Experts discussed the efficacy and durability of immunotherapy responses in patients with NSCLC.
Assessing Immunotherapy Options for PD-L1 NSCLC
A panel of experts focused on the use of dual immunotherapy options for patients with metastatic NSCLC without driver mutations.
City of Hope Claims Victory After Updated CROWN Presentation Data in NSCLC
Experts in non–small cell lung cancer met to debate the latest advances and treatment options and the hottest topics in the space.
